Please ensure Javascript is enabled for purposes of website accessibility

Why Canopy Growth, Aurora Cannabis, and HEXO Stocks Are Up Today

By Rich Smith - Feb 9, 2021 at 1:00PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy promises investors a profit, but didn't quite deliver it this time.

What happened

Marijuana stocks are rallying today. At 11:25 a.m. EST on Tuesday, Canopy Growth (CGC) was up a strong 10.1%, and cannabis rivals Aurora Cannabis (ACB) and HEXO (HEXO) were doing even better, each up 11.4%.

And the reason all these stocks are doing well is Canopy itself.

Rising stock chart is labeled Cannabis Inc with dollar signs and marijuana leaves decorating

Image source: Getty Images.

So what

This morning, Canopy Growth announced its earnings for the fiscal third quarter of 2021, claiming record revenue of 153 million Canadian dollars ($120 million), up 23% year over year, and predicting that it will begin turning revenue into profit by the second half of fiscal 2022. Working off Canopy's somewhat accelerated financial calendar, this implies that the company is only a year away from profitability. Canopy says it sees potential for cannabis reform in the United States that will help it reach this goal.  

Implied in that promise of profits a year from now is the admission that Canopy Growth is not yet profitable today. Gross profit margins at the company plunged 15 full percentage points in the third quarter of 2021, versus the year-ago period, landing at just 16%. Net losses jumped more than 600%, to $829 million.

And Canopy burned through $135 million in negative free cash flow.

Now what

Despite all the negative numbers, Canopy Growth expressed optimism about the medium-term future. It predicted that with help from an opening-up of the U.S. market, it will accelerate its revenue growth from the 23% pace set in the third quarter, to 40% to 50% growth rates from fiscal 2022 through fiscal 2024.

The company also predicted that it will achieve positive adjusted EBITDA in the fiscal second half of 2022, positive operating cash flow by the end of fiscal 2023, and positive free cash flow in fiscal 2024.

All this news is specific to Canopy, so its qualified promise of profitability in a year doesn't mean that Aurora Cannabis and HEXO will also turn profitable alongside it. That being said, Canopy has set the stage for Aurora's own earnings report, which should arrive sometime in the next few days, and HEXO's report, due probably in late March.

Investors bidding up those shares today will hope that the news they have to report will be at least as good as what Canopy just reported -- and hopefully, even better.  

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Stock Quote
Canopy Growth
Aurora Cannabis Stock Quote
Aurora Cannabis
HEXO Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.